A 52-Week, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Safety and Tolerability of GSK573719/GW642444 and GSK573719 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Clinical trial NCT01316887 · COMPLETED
Trial details
- NCT number
- NCT01316887
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2012-07-01
- Enrollment
- 563
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.